Dr Agarwals Eye Hospital logo

Dr Agarwals Eye Hospital financials: balance sheet, profit and loss, cash flow

NSE: DRAGARWQBSE: 526783Healthcare ServicesSmall Cap

Dr Agarwals Eye Hospital Limited · Face value ₹10 · Listed Apr 1995
Last close ₹5,317.50up ₹18.00 (0.34%)BSE ₹5,280.15

Share price at the NSE close on 30 Oct 2026. Previous close ₹5,299.50.

30 Oct: open ₹5,235.00, high ₹5,414.00, low ₹5,235.00

52-week range of BSE trades to 30 Oct 2026
₹4,412.05Low, 30 Jan 2026₹6,392.00High, 2 Jan 2026
Market cap
₹2,570 Cr1,094th largest listed
P/E
33.72
P/B
7.42
Dividend yield
0.13%
ROE
27.4%
ROCE
24.5%
Debt to equity
0.24
Volume, NSE
95464.6% delivered

Dr Agarwals Eye Hospital's financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them.

10 years at a glance

₹ crore, years to March.Dr Agarwals Eye Hospital annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
1496.6Mar 171536.8Mar 181701218Mar 191761413Mar 20140−1.417Mar 212012432Mar 222683744Mar 233194651Mar 243975596Mar 254717082Mar 26
Peak revenue ₹471 Cr, year to Mar 2026; lowest ₹140 Cr, year to Mar 2021A loss in 1 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
30.9%−1.0%14.5%15.3%17.0%26.3%21.7%28.7%27.9%28.5%29.8%30.9%4.4%4.4%7.0%7.8%−1.0%12.0%13.8%14.5%13.8%14.9%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 30.2% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue471
  2. Materials and goods−47
  3. Employee costs−92
  4. Other expenses−187
  5. Operating profit145
  6. Depreciation−46
  7. Other income+5.8
  8. One-off items0.0
  9. Finance costs−12
  10. Profit before tax94
  11. Tax−24
  12. Net profit70

What the company owns

  • Plant, investments and other assets₹638 Cr
  • Current investments₹89 Cr
  • Receivables₹19 Cr
  • Inventory₹14 Cr
  • Cash and bank₹7 Cr

What pays for it: net worth and liabilities

  • Net worth₹346 Cr
  • Other liabilities₹312 Cr
  • Borrowings₹82 Cr
  • Owed to suppliers₹27 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Dr Agarwals Eye Hospital quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 20 MayJun 2026Twelve monthsFiled 3 Aug
Revenue from operations149153170176140201268319397471497
127130141130109144193228279326345
Materials and goods bought1834382216233034424748
Employee costs––343632395364789297
Other expenses––70726182110131158187200
Operating profit before depreciation2123294630587591119145151
Operating margin14.5%15.3%17.0%26.3%21.7%28.7%27.9%28.5%29.8%30.9%30.5%
Materials, % of revenue––22.1%12.5%11.6%11.4%11.1%10.6%10.6%10.0%9.7%
Employee costs, % of revenue––19.9%20.3%23.0%19.1%19.9%20.0%19.7%19.5%19.5%
Other expenses, % of revenue––41.0%41.0%43.6%40.8%41.1%41.0%39.9%39.7%40.3%
Depreciation and amortisation910112119202027394647
Operating profit after depreciation131418251137556479100105
Other income02231125567
Finance costs33386677131210
One-off items––000000000
Profit before tax1013172063249627194101
3766781216162425
Net profit771214−1243746557076
Other comprehensive income––−100−100000
Total comprehensive income––1113−1243746557076
Net margin4.4%4.4%7.0%7.8%−1.0%12.0%13.8%14.5%13.8%14.9%15.3%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations407388103104108113118137
366477909396103105125
Materials and goods bought51520222424253218
Operating profit before depreciation4910131112101312
Operating margin10.1%12.6%11.9%12.2%10.5%11.0%8.8%10.9%8.4%
Depreciation and amortisation356665669
Operating profit after depreciation144657473
Other income111121320
Finance costs144444334
Profit before tax111434450
Tax00021110−1
Net profit001223260
Net margin0.4%0.3%0.6%2.0%1.5%2.9%2.2%4.8%0.0%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 20 May
46565578113157210346
Share capital55555555
Reserves41515073109152205341
1813173244519682
35394953558187111
194552182222258317309
Total assets100141155314390496613766
70111111263343436557630
30304451476056137
Net debt136−53161872−14
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 20 May
3457709094145
376681103115154
66010−66
Receivables−4−10−4−1−6
Inventories3−10−4−4−1
Payables680702
Other working capital20011−111
Tax paid−3−9−12−14−20−9
Capital spending1147717110198
Free cash flow2310−118−747
−11−46−71−70−133−174
−8−40−141725
Dividends paid001323
Shares bought back000000
Shares issued0000070
Net change in cash157−16−22−4
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Dr Agarwals Eye Hospital dividend history

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 20 May
Earnings per share₹13.98₹14.42₹25.35₹29.11−₹3.06₹51.29₹78.55₹98.64₹116.28₹147.02
Diluted earnings per share₹13.98₹14.42₹25.35₹29.11−₹3.06₹51.29₹78.55₹98.64₹116.28₹147.02
Dividend per share₹1.50₹1.20₹1.50––₹3.00₹3.00₹5.00₹6.00₹7.00
Book value per share––₹97.00₹119.36₹116.30₹166.33₹241.15₹334.36₹445.98₹716.98
Dividend payout10.7%8.3%5.9%––5.8%3.8%5.1%5.2%4.8%
Shareholder yield––––0.0%0.0%0.3%0.2%0.1%−2.9%
Market cap at the year end (₹ crore)141282171901473444301,4591,9052,271

Ratios

Standalone, years to March.Dr Agarwals Eye Hospital PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 20 May
Revenue growth8.8%3.2%10.9%3.5%−20.5%43.9%33.1%19.2%24.4%18.6%
Operating profit growth86.8%9.0%23.5%59.7%−34.3%89.9%29.5%21.9%30.1%22.6%
Net profit growth17,662.2%3.1%75.9%14.8%––53.2%25.6%17.9%28.3%
Earnings per share growth17,375.0%3.1%75.8%14.8%––53.2%25.6%17.9%26.4%
––26.1%26.9%−2.6%36.3%38.6%34.3%29.8%25.2%
–––0.8 pts−29.5 pts38.9 pts2.3 pts−4.3 pts−4.5 pts−4.6 pts
From the net margin–––2.9 pts−30.5 pts32.8 pts5.5 pts2.1 pts−1.8 pts2.4 pts
From asset turnover–––−4.0 pts1.3 pts−2.8 pts−4.7 pts−2.1 pts−0.2 pts−1.5 pts
From borrowing–––1.9 pts−0.3 pts8.9 pts1.5 pts−4.2 pts−2.5 pts−5.5 pts
Return on capital employed––28.3%36.0%15.8%33.9%34.7%30.9%25.8%23.3%
Cash conversion–––––235.1%188.6%193.6%172.9%207.0%
Interest cover3.95.37.03.21.86.07.99.05.98.4
Debt to equity––0.400.240.310.410.390.330.460.24
Receivable days––1914231614151315
Inventory days––631321179173106117109
Payable days––149224400410327345263208
Cash conversion cycle, days––−67−78−260−303−240−224−133−84
Working capital days––−11−25−52−36−39−55−38−43
Asset turnover––1.701.460.950.860.760.720.720.68
Assets per rupee of net worth––2.202.372.673.533.683.273.022.48
Sales per rupee of plant––3.253.182.453.423.142.642.481.26
Capital spending to depreciation––––0.592.293.512.682.572.16
Plant being built, % of plant in use––0.5%0.0%0.0%45.0%72.9%80.6%79.9%52.6%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
10.2%
Cash from operations against operating profit
99.9%
Measure10 years5 years3 years
Revenue growth, yearly rate13.2%27.5%20.7%
Profit growth, yearly rate112.7%–23.8%
Return on equity, average–32.8%29.8%
Return on capital employed, average–29.7%26.7%
Operating margin, average24.1%29.2%29.7%
Net margin, average9.2%13.8%14.4%
Asset turnover, average–0.750.71
Cash conversion cycle, days, average–−197−147
Interest cover, average5.87.47.8
Debt to equity, average–0.360.34

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations456329145
Cash from investing−493−376−174
Cash from financing242725
Capital spending38927198
Dividends paid983
Shares bought back000
Shares issued for cash707070
Borrowings raised121710
Borrowings repaid613315

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––585747
Altman Z-scorePublished threshold 1.81––4.742.972.452.242.464.074.344.97
Beneish M-scorePublished threshold −1.78––––−3.24−2.38−2.63−2.68−2.73−2.71
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−16.465.8410.776.0116.7614.28
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––2.692.011.841.93
Receivables growth less revenue growthOur threshold 0 percentage points–––−25.1050.22−45.13−16.568.70−16.3415.37
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––64.31−8.36−30.88−25.6449.4512.96−6.86
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––0.770.570.75−2.130.340.090.89
Assets under construction, years of additionsOur threshold 2 years of additions–––0.000.001.191.331.571.630.76
Effective tax ratePublished threshold 17.16 per cent32.9649.2931.6231.38125.0925.4025.2625.5322.7025.11
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−2.251.943.66−5.7715.46
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
15 Jun 2026CRISIL Ratings LimitedBank FacilitiesLong-term scaleWithdrawnRating Withdrawn29
15 Jun 2026CRISIL Ratings LimitedBank FacilitiesLong-term scaleWithdrawnRating Withdrawn31
15 Jun 2026CRISIL Ratings LimitedBank FacilitiesLong-term scaleWithdrawnRating Withdrawn16
15 Jun 2026CRISIL Ratings LimitedBank FacilitiesWithdrawnReview, Other4
15 Jun 2026CRISIL Ratings LimitedBank FacilitiesLong-term scaleWithdrawnRating Withdrawn50
23 Feb 2026ICRA LimitedUnallocated limits-Unallocated limitsLong and short-term scales[ICRA]AA- /[ICRA]A1+New, NewStable54.20
23 Feb 2026ICRA LimitedFund-based-Term loanLong-term scale[ICRA]AA-New, NewStable85.80
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.